Cueto-Robledo Guillermo, Roldan-Valadez Ernesto, Guerrero-Velazquez Jose-Francisco, Orozco-Zuñiga Benjamin, Cueto-Romero Hector-Daniel, Rivera-Sotelo Nathaly, Garcia-Cesar Marisol, Torres-Rojas Maria-Berenice, Graniel-Palafox Luis-Eugenio
Cardiorespiratory Emergencies, Hospital General de México "Dr Eduardo Liceaga", Mexico City, Mexico; Pulmonary Circulation Clinic, Hospital General de México "Dr. Eduardo Liceaga", Mexico City, Mexico; National Autonomous University of Mexico, Mexico City, Mexico.
Hospital General de Mexico "Dr. Eduardo Liceaga," Mexico City, Mexico; I.M. Sechenov First Moscow State Medical University (Sechenov University), Department of Radiology, Moscow, Russia.
Curr Probl Cardiol. 2023 Feb;48(2):101462. doi: 10.1016/j.cpcardiol.2022.101462. Epub 2022 Oct 17.
Pulmonary embolism (PE) worldwide is an underdiagnosed disease; at the moment, there are no statistical data to make inferences regarding the thrombotic problem in Mexico. Although, in general, small emboli (subsegmental) are well tolerated in the pulmonary circulation, difficulties frequently occur for medium to large emboli that occlude more than 30% of the pulmonary circulation. In the United States, it is estimated that up to 100,000 PE-related deaths occur each year. A PE code consists of activating a group of specialists in PE for the consensual making of therapeutic decisions; it is beneficial for the clinical evolution of these patients and reduces their mortality; a PE response team (PERT) codes in reference hospitals to manage this disease. This report presents an updated summary of the PERT status globally and in Mexico, the explanation of why a PE code is necessary, and the effects of PERT teams in the detection (chronic thromboembolic pulmonary hypertension, chronic thromboembolic disease, and venous thromboembolism); therapeutic procedures (catheter-directed thrombolysis, systemic thrombolysis or surgical thrombectomy); selection of patients from low to high risk of PE; and future directions for PERT teams.
全球范围内，肺栓塞（PE）是一种诊断不足的疾病；目前，尚无统计数据可用于推断墨西哥的血栓形成问题。尽管一般来说，小栓子（亚段栓子）在肺循环中耐受性良好，但对于阻塞超过30%肺循环的中到大栓子，常常会出现问题。在美国，据估计每年有多达10万例与肺栓塞相关的死亡。肺栓塞代码（PE code）包括召集一组肺栓塞专家共同做出治疗决策；这对这些患者的临床进展有益，并降低其死亡率；在参考医院设立肺栓塞反应小组（PERT）代码以管理这种疾病。本报告介绍了全球及墨西哥PERT的最新概况、为何需要肺栓塞代码的解释，以及PERT小组在检测（慢性血栓栓塞性肺动脉高压、慢性血栓栓塞性疾病和静脉血栓栓塞症）、治疗程序（导管定向溶栓、全身溶栓或手术取栓）、从低到高肺栓塞风险患者的选择以及PERT小组未来方向等方面的作用。
